Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

BJE6-106

Copy Product Info
😃Good
Catalog No. T10555Cas No. 1564249-38-2
Alias BJE6106, BJE6 106, B-106, B106, B 106

BJE6-106 (B106) is a selective PKCδ inhibitor (IC50 = 0.05 μM) with 1000-fold higher selectivity for PKCδ than PKCα (IC50 = 50 μM). BJE6-106 induces caspase-dependent apoptosis, activates the JNK pathway and H2AX, and can be used to study NRAS-mutated melanoma.

BJE6-106

BJE6-106

Copy Product Info
😃Good
Catalog No. T10555Alias BJE6106, BJE6 106, B-106, B106, B 106Cas No. 1564249-38-2
BJE6-106 (B106) is a selective PKCδ inhibitor (IC50 = 0.05 μM) with 1000-fold higher selectivity for PKCδ than PKCα (IC50 = 50 μM). BJE6-106 induces caspase-dependent apoptosis, activates the JNK pathway and H2AX, and can be used to study NRAS-mutated melanoma.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$149-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
BJE6-106 (B106) is a selective PKCδ inhibitor (IC50 = 0.05 μM) with 1000-fold higher selectivity for PKCδ than PKCα (IC50 = 50 μM). BJE6-106 induces caspase-dependent apoptosis, activates the JNK pathway and H2AX, and can be used to study NRAS-mutated melanoma.
Targets&IC50
PKCδ:0.05 μM, PKCα:50 μM
In vitro
BJE6-106 (0.2/0.5 μM; 6–24 hours) induces caspase-dependent apoptosis in SBcl2 cells, enhancing caspase 3/7 activity [1].
BJE6-106 (0.2/0.5 μM; 24–72 hours) inhibits survival of melanoma cell lines harboring NRAS mutations [1].
BJE6-106 (0.5 μM; 2–10 hours) induces JNK, MKK4, and H2AX activation in SBcl2 cells, activating the MKK4-JNK-H2AX pathway [1].
SynonymsBJE6106, BJE6 106, B-106, B106, B 106
Chemical Properties
Molecular Weight381.47
FormulaC26H23NO2
Cas No.1564249-38-2
SmilesO=CC1=CC(=CC=2C=CC(OC12)(C)C)CCN3C=4C=CC=CC4C=5C=CC=CC53
Relative Density.1.16 g/cm3 (Predicted)
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 40 mg/mL (104.86 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.6214 mL13.1072 mL26.2144 mL131.0719 mL
5 mM0.5243 mL2.6214 mL5.2429 mL26.2144 mL
10 mM0.2621 mL1.3107 mL2.6214 mL13.1072 mL
20 mM0.1311 mL0.6554 mL1.3107 mL6.5536 mL
50 mM0.0524 mL0.2621 mL0.5243 mL2.6214 mL
100 mM0.0262 mL0.1311 mL0.2621 mL1.3107 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy BJE6-106 | purchase BJE6-106 | BJE6-106 cost | order BJE6-106 | BJE6-106 chemical structure | BJE6-106 in vitro | BJE6-106 formula | BJE6-106 molecular weight